The Effect of Weight Loss With Orlistat or Sibutramine Administration, Hypocaloric Diet and Physical Exercise, on AMH Levels, in Women With Polycystic Ovary Syndrome

Trial Profile

The Effect of Weight Loss With Orlistat or Sibutramine Administration, Hypocaloric Diet and Physical Exercise, on AMH Levels, in Women With Polycystic Ovary Syndrome

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2015

At a glance

  • Drugs Orlistat (Primary) ; Sibutramine (Primary)
  • Indications Obesity; Polycystic ovary syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 23 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top